Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -10.72%-170.19K | 33.96%-316.08K | 69.53%-202.98K | -426.88%-2.09M | -749.41%-790.26K | 40.65%-153.71K | -21,905.06%-478.62K | -1,329.85%-666.26K | -27.96%-396.45K | -93.04K |
| Net income from continuing operations | -20.49%-357.96K | 25.14%-319.47K | -30.01%-431.64K | -14.62%-1.79M | -166.47%-730.98K | 24.93%-297.09K | 42.26%-426.76K | -121.57%-332K | -124.65%-1.56M | ---274.32K |
| Operating gains losses | ---- | ---- | ---- | -604.35%-37.08K | --46.26K | ---- | ---- | -637.74%-83.33K | -441.82%-5.26K | --0 |
| Depreciation and amortization | 280.21%2.15K | -61.05%370 | 95.22%1.84K | --2.59K | --128 | --566 | --950 | --942 | --0 | --0 |
| Asset impairment expenditure | --0 | --0 | --4.35K | --173.92K | --173.92K | --0 | --0 | --0 | --0 | ---- |
| Remuneration paid in stock | 2.96%72.01K | -23.04%53.25K | -1.28%52.66K | --389.61K | --197.13K | --69.95K | --69.19K | --53.34K | --0 | --0 |
| Deferred tax | ---- | ---- | ---- | -200.00%-69.35K | ---- | ---- | ---- | ---- | --69.35K | ---- |
| Other non cashItems | 42.86%-17.19K | --10.25K | --9.91K | -721.43%-100.09K | ---70.02K | ---30.08K | ---- | ---- | --16.11K | ---- |
| Change In working capital | 27.05%130.79K | 50.43%-60.48K | 152.39%159.9K | -160.23%-661.61K | -401.37%-337.35K | -26.39%102.94K | -116.08%-122K | -447.84%-305.21K | 294.29%1.1M | --111.94K |
| -Change in receivables | -205.05%-6.45K | 967.66%46.68K | -54.31%-33.28K | 11.02%-26.13K | -184.76%-5.32K | 154.29%6.14K | 55.62%-5.38K | -76.45%-21.57K | -1,207.70%-29.37K | --6.28K |
| -Change in prepaid assets | 246.49%25.91K | -259.24%-15.02K | 359.41%139.61K | -2,762.52%-189.81K | -1,826.41%-127.74K | -255.83%-17.69K | 191.02%9.43K | -5,341.66%-53.82K | -288.81%-6.63K | ---6.63K |
| -Change in payables and accrued expense | -2.77%111.33K | 26.90%-92.14K | 123.31%53.58K | -143.32%-445.66K | -281.93%-204.29K | -18.11%114.5K | -118.66%-126.05K | -327.64%-229.82K | 270.94%1.03M | --112.29K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --105.72K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -10.72%-170.19K | 33.96%-316.08K | 69.53%-202.98K | -426.88%-2.09M | -749.41%-790.26K | 40.65%-153.71K | -21,905.06%-478.62K | -1,329.85%-666.26K | -27.96%-396.45K | ---93.04K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 6.21%-160.07K | 154.96%81.18K | -116.10%-263.08K | -182.13%-826.02K | -368.02%-385.92K | -27.50%-170.66K | -19.28%-147.7K | 32.02%-121.74K | -292.78K | 143.99K |
| Net PPE purchase and sale | --0 | --81.18K | ---51.6K | ---1.71K | -102.68%-1.71K | --0 | --0 | --0 | --0 | --63.74K |
| Net business purchase and sale | --0 | --0 | --0 | --13.7K | -52.05%39.16K | --0 | 7.10%-29.94K | --4.49K | --0 | --81.66K |
| Net investment purchase and sale | --0 | --0 | ---11.5K | --0 | --0 | --0 | --0 | --0 | ---123.53K | ---1.41K |
| Net other investing changes | 6.21%-160.07K | ---- | -58.42%-199.97K | -395.14%-838.01K | -764.24%-423.36K | -26.17%-170.66K | -173.42%-117.76K | -21.27%-126.23K | ---169.25K | --63.74K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 6.21%-160.07K | 154.96%81.18K | -116.10%-263.08K | -182.13%-826.02K | -368.02%-385.92K | -27.50%-170.66K | -19.28%-147.7K | 32.02%-121.74K | ---292.78K | --143.99K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -44.32%219.95K | 0 | 0 | 540.20%4.05M | 1,743.56%1.79M | -15.50%395.05K | 0 | 881.40%1.86M | 631.89K | -108.7K |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --123.53K | ---- |
| Net common stock issuance | --0 | --0 | --0 | 540.20%4.05M | 1,916.16%2.18M | --0 | --0 | 881.40%1.86M | --631.89K | --108.21K |
| Net other financing activities | -44.32%219.95K | ---- | ---- | ---- | ---- | 67.06%395.05K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -44.32%219.95K | --0 | --0 | 540.20%4.05M | 1,743.56%1.79M | -15.50%395.05K | --0 | 881.40%1.86M | --631.89K | ---108.7K |
| Net cash flow | ||||||||||
| Beginning cash position | -3.95%482.39K | -36.44%717.29K | 2,140.54%1.18M | -55.12%52.82K | 374.27%572.9K | 1,866.72%502.22K | 1,245.44%1.13M | -55.12%52.82K | -70.34%117.69K | --120.8K |
| Current changes in cash | -256.08%-110.31K | 62.50%-234.9K | -143.32%-466.06K | 2,071.52%1.13M | 1,156.99%610.45K | -5.30%70.68K | -1,529.31%-626.32K | 3,106.85%1.08M | 81.49%-57.34K | ---57.75K |
| Effect of exchange rate changes | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---7.53K | ---10.23K |
| End cash Position | -35.05%372.08K | -3.95%482.39K | -36.44%717.29K | 2,140.54%1.18M | 2,140.54%1.18M | 374.27%572.9K | 1,866.72%502.22K | 1,245.44%1.13M | -39.30%52.82K | --52.82K |
| Free cash from | -10.72%-170.19K | 33.96%-316.08K | 61.79%-254.58K | -427.31%-2.09M | -751.25%-791.97K | 40.65%-153.71K | -21,905.06%-478.62K | -1,329.85%-666.26K | -27.96%-396.45K | ---93.04K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.